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Abstract 
Autism is gradually becoming an epidemic. The frequency of this disorder now is one per 60–80 infants, 
against 1:5000-10000 approximately 60–70 years ago. Because epidemics of genetic disease do not 
occur, this confirms that most cases of autism are not associated with the genome problems but rather 
with the progressive deepening of environmental problems. Environmental pressure may be barely 
noticeable for an adult, but this could disturb the development of a much more fragile foetus. A variety of 
industrial and agricultural pollutants, heavy metals, pathogenic bacteria, etc. may be involved in the 
pathogenesis of autism. All of them cause similar persistent changes in the production of autoantibodies 
and cytokines influencing the foetal development. Moreover, trans-placental transfer of the excess of 
some maternal аuto-antibodies of IgG class leads to pre-birth ‘tuning’ of the immune system of the foetus 
by mechanisms of maternal immune imprinting. This phenomenon could be an additional factor in the 
pathogenesis of autism. It is noted that the environment-induced immune changes are mostly adaptive for 
the mother; however, for the unborn child, they can often be the factors of pathogenesis. Discuss the 
possibility of the study of repertoires of maternal autoantibodies for the prediction of normal or abnormal 
development of the foetus and the birth of the newborn with congenital disorders that are not caused by 
gene defects. 
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Introduction 
The frequency of the birth of children with autism 
spectrum disorders (ASD) is now one in 60-80 
newborns, compared with 1: 5,000-10,000 more 
60-70 years ago. The most likely cause of this 
increase in the frequency of ASD is the 
progressively growing environmental 
disadvantage. Excess man-caused pollutants, 
herbicides, insecticides in water, air or food, 
malnutrition, microbiocenosis disorders, etc., can 
cause long-term changes in the woman's immune 
system, which include long-term shifts in the 
production of a number of autoantibodies. For the 
mother's body, such changes are usually adaptive 
(protective), however, for an immature foetus they 
are often pathogenesis factors leading to the onset 
of ASD and / or other congenital disorders. In 
ASD, multi-system disturbances are typical i.e. 
neurological disorders almost always combine 
with somatic disorders. The organs that suffer 
most often are the intestines, pancreas, lungs, 
pelvic organs, kidneys and adrenals (Rossignol, 
Frye, 2012; Poletaev, Shenderov, 2018). It is not 
surprising that the mortality from somatic causes 
in such children is higher 3-10 or more times 
(depending on the severity of autism) than the 
mortality rate of healthy children of the same age 
groups (Treating Autism Publications, 2013). It 
should be noted that effective correction of 
somatic disorders leads to positive changes in the 
behaviour of children in full accordance with the 
expression "Mens sana in corpore sana" (in a 
healthy body - a healthy mind).  
The exponential growth of ASD leads to an 
increase in the burden on society. Gradually the 
problem outgrows the medical framework and 
becomes a general social issue. Obviously, in 
order to find its solution, it is necessary to pay 
much more attention to the study of the causes of 
ASD and mechanisms for the development of 
violations. Only a deep understanding of the 
epidemic can afford to stop the growth of the 
ASD and focusing on preventing the occurrence 
of this disorder instead of correction of affected 
children. 
Epigenetic Autism 
As a result of the analysis of hundreds of articles 
on the problems of ASD (publications 1971 - 
2010 from the most prestigious medical journals), 
Rossignol and Frye (Rossignol, Frye, 2012) came 
to the following conclusions:  
1) Only 6-15% of cases of RAS are directly 
associated with genetic defects (according to 
other data less than 3% (Treating Autism 
Publications, 2013)).  
2) In 85-95% of cases, the causes of RAS are 
epigenetic factors. 
3) Among the latter, the leading role is played 
by immune disorders and inflammatory 
processes. Its contribution is also brought by 
toxic effects, mitochondrial dysfunction and 
oxidative stress.   
In most cases, the changes underlying the ASD 
are phenotypic and are not associated with 
irreversible genome defects. Classical autism is a 
multifactorial disease, the development of which 
necessitates the presence of some triggering 
environmental factors (Poletaev, Shenderov, 
2018). The role of factors affecting the body of a 
pregnant woman and capable of inducing the 
formation of ASD in her child can also be caused 
by an imbalance in nutrition, heavy metal salts, 
pesticides and herbicides, chronic inflammatory 
processes, acute infectious diseases and many 
other factors (Poletaev, Shenderov, 2018). The 
factors listed above are characterised by an 
important common property. They all in one way 
or another induce long-term changes in the body 
of a pregnant woman, affecting the state of her 
immune system, and changing the production of 
many antibodies and cytokines (Poletaev et al., 
2014). 
Changes in the immune system of the 
mother as grounds for fetal 
misdevelopment 
The developing foetus is much less resistant to 
any negative effects compared with the organism 
of an adult woman. Therefore, the negative effects 
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of biologically active molecules, in some 
situations synthesized in pregnant women in high 
quantities, affect it particularly noticeably. 
However, changes in the production of highly 
labile pro-inflammatory cytokines (half-lives of 
most of them in vivo do not exceed minutes), 
hardly penetrating trans-placental, are unlikely to 
significantly disturb the development of the 
foetus. At the same time, abnormality in the 
production and content of many IgG 
autoantibodies, half-lives of which are weeks and 
whose actively transported from mother to foetus 
via the placenta, can have a much more 
pronounced effect on the formation of a future 
child (Poletaev, 2008). Under normal conditions, 
maternal antibodies participate in tuning the 
developing immune system of the unborn child 
with the help of maternal immune imprinting 
(Poletaev, 2008; Lemke, Lange, 2009). However, 
too prolonged increase in their production can 
cause damage to the foetus. 
It is known that any disturbances in human organs 
and tissues, even sub-clinical, are accompanied by 
activation of apoptosis or necrosis of certain cells, 
which induces a secondary physiological increase 
in the production of autoantibodies of the 
corresponding specificity (Poletaev, 2013). The 
enhanced synthesis of such molecules allows the 
activation of the clearance of the affected organs 
and tissues from the products of decay (Poletaev, 
2013). However, such protective (sanogenic) 
physiological reaction of the immune system of a 
pregnant woman, manifested in an increase in the 
production of autoantibodies to antigens of 
damaged organs and tissues, can be pathological 
in relation to the foetus. Especially in cases when 
the increase in the production of "neuro-tropic", 
"pancreo-tropic", "pulmo-tropic", "renoto-tropic", 
etc. autoantibodies of a certain organ/tissue 
specificity, turns out to be unduly long and/or 
abnormally intense due to the some features of the 
mother's genotype. Ultimately, this will determine 
the outcome of pregnancy and compensation, or, 
conversely, the clinical manifestation 
(decompensation) of changes in the child's health 
after birth. 
When developing approaches to ASD 
prophylaxis, the main question can be posed as 
follows: are the effects of chronic exposure to 
toxins, pollutants, infectious agents and other 
environmental factors realised through 
disturbances in the immune system of a pregnant 
woman or are the immune changes one of the 
many factors of the pathogenesis of ASD? It is 
obvious that with the first variant, preventive 
measures and correction of the future mothers can 
be directed, mainly, to measures for immune-
correction. Whereas with the second variant of the 
answer, the adequate correction will be 
impossible without additional measures aimed at 
selective normalisation of certain metabolic 
events and other extra-immune disturbances. 
It is clear that the ASD problem, as a global 
problem, can largely be solved only if reliable 
technologies are developed that allow the 
identification of women at risk in advance (before 
their pregnancy), as well as effective approaches 
to eliminate deviations leading to 
misdevelopment of the foetus. On what principles 
can the laboratory methods be useful for the 
identification of women at risk of having children 
with ASD? 
Can variants of polymorphism of 
nucleotides of genomic DNA underlie 
autism? 
As early as 10-15 years ago, the opinion that 
certain genetic defects are the basis of autism was 
dominant (but, since there are no epidemics of 
genetic diseases, even then the epidemic growth 
of ASD was perplexing).  
A small part of typical autistic manifestations is 
noted in children suffering from some 
nosologically defined genetic diseases. For 
example, about 10% of patients with Down's 
syndrome have autistic symptoms. Somewhat 
more often, autistic symptoms are seen in people 
with tuberous sclerosis (in 15-20% of cases), with 
Martin-Bell syndrome, a synonym for fragile X-
chromosome syndrome (typical for 20-40% of 
patients), with Rett syndrome (more than 90 % of 
patients). It is clear that such cases are more 
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correctly considered from the standpoint of the 
underlying disease (Down Syndrome, Rett 
syndrome), but not to separate into a separate 
form "genetic autism" (Poletaev, and Shenderov, 
2018).  
It is necessary to consider also the so-called 
"autistic" SNP (Single Nucleotide 
Polymorphism). The fact is that with the use of 
wide-screened screening (GWAS), it is possible to 
identify quite a few variants of SNP, occurring 
with an increased frequency in the genomes of 
very many children with autism (Anney et al., 
2012). However, the prognostic clinical 
significance of such findings is small. The reason 
is as follows. It is generally accepted that the main 
tool of evolutionary variability is random and 
mostly neutral point mutations that mainly affect 
the non-coding regions of the genome. The 
material expression of such mutations are SNP, 
which are the result of transitions (replacement of 
A by T and T by T), transversions (replacement of 
G by A and T by T), or deletions of single 
nucleotides (Conrad et al., 2006). Random 
nucleotide polymorphisms only in a small part of 
cases affect the functions of certain 
macromolecules (for example, enzymes, receptor 
or transport proteins), minimally changing their 
metabolic activity. In this case, the general 
resistance of the organism to external influences 
can occasionally decrease (as a rule, 
insignificantly). It is clear that reducing the 
resistance of the body to the harmful effects of the 
environment, to some extent will increase the risk 
of developing any disease, including the 
likelihood of the birth of an autistic child. 
However, a decrease in overall resistance is a 
nonspecific feature, and does not mean an 
increased predisposition to any particular 
pathology.   
Thus, widespread genomic screening can hardly 
be useful for the preventive detection of people 
at risk of having children with ASD. Much more 
reason to rely on marker molecules of blood. 
Blood 
Blood (more precisely, blood plasma) can be 
considered as a special substance involved in the 
functional conjugation of all organs, tissues and 
cells into a single organism. Blood is an all-
pervasive environment, somewhat similar to the 
Ether of the Ancients (Ether as an all-pervading 
entity mediating the interactions between all 
objects of the Universe). On the one hand, the 
blood performs utilitarian (house-keeping) 
functions - it brings oxygen and nutrients to the 
tissues and takes out the products of catabolism, 
and on the other hand it is the medium for 
transferring colossal arrays of information to 
which all the structures of the macro-organism 
and all the components of its microbiome. This 
information is transmitted, for the most part, in the 
form of control signals of chemical and possibly 
physical nature (the latter remain practically 
unexplored).   
The cumulative set of chemical signals of blood - 
hormones, growth factors, cytokines, 
chemokines, nucleic acids, antibodies, etc., 
creates in the human body a highly ordered 
information environment that controls a huge 
number of simultaneously occurring biological 
processes. Blood is not only a controlling, but also 
a reflective environment - dynamic changes in its 
composition reflect any minute changes in the 
state of individual cells, tissues, organs and the 
organism as a whole at any period of time. In the 
"mirror" of chemical signals, any pathological 
changes - those that begin and are capable to lead 
to future illnesses, and those that accompanying 
already formed diseases are reflected (Poletaev, 
2017). It would be tempting to have at our 
disposal the necessary technical equipment and a 
mathematical apparatus for analysing correlations 
between changes in the content of a multitude of 
molecular components of blood at different states 
of the organism. This would allow us to tackle 
"bridging" between dynamic changes that occur 
simultaneously at the molecular, cellular, tissue, 
organ, and organism levels in norm and 
pathology. But due to poor knowledge of the 
majority of biologically active components of the 
blood, this can hardly be expected in the 
foreseeable future.  
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Peptides of blood. Oligopeptide (less than 50 
amino acid residues) hormone-like molecules that 
participate in the regulation of a variety of 
physiological functions are very important as 
intercellular and intersystem communicators. 
Oligopeptides participate in the modulation of 
neurophysiological mechanisms of the main 
motivations, as well as the mechanisms of 
learning and memory. Changes in the ratio 
between many dozens of pro-inflammatory and 
anti-inflammatory blood plasma cytokines set the 
developmental vectors of local and systemic 
immune-inflammatory and regenerative 
processes (Zaichik, Churilov, 2007). However, 
the regulatory functions of oligopeptides have 
been studied very poorly. 
Micro-RNA and extracellular DNA. Even less 
studied is a separate "kingdom" of circulating 
thousands of short (usually 18-25 nucleotides) 
interfering molecules of micro-RNA, potentially 
capable of operatively controlling gene 
expression and, consequently, participating in the 
regulation of a wide range of physiological 
processes (Aushev, 2015). These issues need 
further study. Assumed, although less studied, the 
regulatory properties of extracellular DNA 
(Tuaeva et al., 2008). 
Exogenous regulatory molecules of blood. 
Since the beginning of the 21st century, 
biologically active molecules of extra-organism 
origin, involved in the regulation of body 
functions, have attracted noticeable attention. For 
example, it was recently discovered that 
molecules synthesized by symbiotic microflora 
participate in the regulation of the physiological 
functions of the macro-organism. For example, 
short-chain fatty acids of microbial origin may be 
ligands of some olfactory chemoreceptors in the 
walls of blood vessels and participate in the 
regulation of vascular tone (Pluznick, 2017). And 
the products of partial hydrolysis of food entering 
the general bloodstream from intestinal villi can 
affect the emotional status of children and adults. 
As, for example, peptide ligands of opiate 
receptors in the brain (so-called exorphins 
(Teschemacher, 2003)).   
Data on typical changes in the endogenous opiate 
system for children with ASD and their mothers 
(Poletaev et al., 2016; Khmelnitskaya, 2017) can 
be used to develop ways to correct such children. 
The endogenous opiate system appeared as a 
system of positive reinforcement of the behavior 
of the individual's survival and the species as a 
whole - it provides emotional reinforcement of 
food, drinking and sexual behaviour. Opiate 
receptors are abundantly present in the brain and 
in the small intestine. The latter may be due to the 
fact that many food products contain a 
composition of proteins that have in their structure 
peptide fragments - opiate receptor ligands 
(exorphins). In particular, one of the main proteins 
of milk casein contain a few fragments called β-
casomorphins, and the wheat protein gluten 
contains a number of glutorphins. It is assumed 
that eating disorders (bulimia, anorexia) are often 
associated with an inadequate reaction of the 
individual's opiate system to food exorphins. 
Activation of opiate receptors leads to an increase 
in food intake, and the introduction of their 
antagonists reduces hunger and inhibits food 
intake (Teschemacher, 2003; Poletaev et al., 2016; 
Khmelnitskaya, 2017). Such data justify the 
empirical experience of using a gluten-free and 
casein-free diet in children with ASD, which 
presumably eliminates the excessive stimulation 
of their opiate system.  
The role of biologically active products of 
microbiota, as well as the derivatives of food 
entering the general circulation, is just beginning 
to be explored. The structure and functions of a 
very large number of small RNAs, extracellular 
DNA and peptide (oligopeptide) regulatory 
molecules of blood plasma have also been studied 
very poorly. Their study is hampered by the high 
lability of most of them and the high cost of 
research. In this respect, the advantage belongs to 
others, probably the most numerous and most 
diverse information macromolecules of blood, 
namely antibodies. It is important that the 
antibodies are very stable, and their 
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concentrations are 2-3 orders of magnitude higher 
than the concentrations of both oligopeptides and 
extracellular nucleic acids.  
Immune reflection  
More than a century ago Ilya Mechnikov 
suggested that the fight against harmful microbes 
is no more than one of the particular 
manifestations of the broad homeostatic functions 
of the immune system (Poletaev, 2008). In the last 
15-20 years, the understanding that the immune 
system is a reflexive system has validated 
Mechnikov's suggestions. The immune system 
reflects any persistent changes in the body, 
occurring at the level of molecules, cells, tissues 
and organs. Including those that are typical for 
women at risk of having autistic children and 
children with ASD.  
Today, the overall role of the immune system is 
considered on the basis of the following 
provisions: The immune system provides a 
constant screening of the molecular structure of 
the body. It supports general homeostasis through 
participation in auto-clearance, auto-reparation 
and functional co-tuning of many different cells, 
tissues and organs of an organism. The immune 
system eliminates harmful microorganisms, but 
ignores the "alien" that does not pose a threat, and 
actively promotes the integration of a useful 
"aliens" into the structure of the organism (for 
example, mitochondria, once autonomous 
microorganisms). Natural autoantibodies and 
autoreactive lymphocytes are the main tools of 
immune reflection and immune clearance of the 
body (Cohen, Young, 1991; Matzinger, 2002; 
Parnes, 2004; Poletaev, 2013; Tauber, 2014). 
Serological tests for antibodies to pathogenic 
microbes have long become routine - increasing 
the titers of specific antibodies is judged by the 
presence of appropriate viruses or bacteria in the 
body. Similarly, increasing the production of its 
own antigens causes an increase in the synthesis 
of antibodies to them. For example, increasing the 
expression of insulin receptors in many months 
and years precedes the development of type 2 
diabetes and is accompanied by the growth of 
anti-receptor antibodies (Poletaev, 2013), and the 
increased synthesis of the p53 protein regulating 
apoptosis leads to an increase in the production of 
antibodies to this protein (Poletaev, 2017). These 
examples illustrate the phenomenon of immune 
reflection, or the ability of the immune system to 
respond operatively to quantitative changes in the 
production of antibodies to changes in the content 
of ANY antigens ("self" and "alien") in the 
human body. Antibodies of corresponding 
specificity mark particles or molecules destined 
for macrophage consumption-and-disposal and 
increase the phagocytic activity of the latter tens 
and hundreds of times. The content of 
autoantibodies of different specificity may vary 
significantly, but the serum levels of 
autoantibodies of each one specificity are very 
close in all healthy individuals (Poletaev, 2013). 
With any pathological changes, the synthesis of 
autoantibodies of the corresponding specificity 
increases, which changes the relationship between 
these antibodies and antibodies of any other 
specificity, and the profiles of serum 
immunoreactivity in general.  
Conclusion 
The information available today does not allow us 
to make unequivocal conclusions about the 
relative role of immunocompromised and extra-
immune disorders in the development of autism 
and many other congenital developmental 
disorders. This issue urgently requires a serious 
experimental and clinical study. Nevertheless, the 
arguments outlined above allow us to assume the 
following sequence of main events leading to the 
development of epigenetic autism.  
1. In situations where women of childbearing age, 
the long-term eating of a hazard foods, micro-
ecological disorders in the microbiome, toxic 
chemical factors and infectious antigens, 
persistent immune-metabolic changes inevitably 
develop over time.  
2. The individual's resistance to negative 
influences of the environment and, accordingly, 
the timing of the appearance of pathological 
changes in organs and tissues, their severity and 
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the rate of their progression, will to a large extent 
be determined by the individual characteristics of 
the genome. 
3. The onset of pregnancy against the background 
of the steady immuno-metabolic changes may 
lead to more pronounced or less pronounced 
disorders in the formation and maturation of brain 
structures and other organs and systems of the 
developing foetus, the degree of expression of 
which will be determined by the individual 
stability of the future child associated with the 
characteristics of his genome. 
The proposed scheme for the development of 
ASD and other congenital disorders not 
associated with genome defects may require 
additional detail. First of all, it can touch the role 
and significance of extra-immune components of 
the pathogenesis of ASD. However, in our 
opinion, it is doubtful that the proposed scheme 
will be completely revised. 
The widespread increase in the frequency of 
occurrence of ASD, which in recent decades has 
acquired the nature of an epidemic, and possibly a 
pandemic, clearly requires the rapid development 
of preventive measures. It is important to 
understand that any medical measures, if they are 
aimed only at helping the victims (even the most 
effective ones), will hardly allow to stop the 
further spread of the epidemic. We believe that to 
date, many convincing evidence have been 
obtained that the immune system plays an 
important role in the pathogenesis of ASD, and 
some autoantibodies can be used as marker 
molecules of this pathology. Accordingly, it can 
be hoped that the development of specialised 
immunochemical methods for the analysis of 
such markers will soon find application for mass 
screening of children in the first months of life 
and in identifying situations that threaten the 
development of ASD. An equally important task 
will be the organisation of screening for women 
planning a pregnancy. The purpose of this 
screening will be to identify and early (before 
pregnancy) correction of changes in the health 
status of women, dangerous for foetal 
development. Such approaches can be very 
effective in preventing (reducing the frequency) 
the birth of children with autism and other 
congenital disorders not caused by defects in the 
genome. 
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